93 related articles for article (PubMed ID: 15957829)
1. [Effect of astraglus injection on serum apoptosis relevant factors in patients with chronic heart failure].
Zhang JG; Yang N; He H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 May; 25(5):400-3. PubMed ID: 15957829
[TBL] [Abstract][Full Text] [Related]
2. [Effect of Astragalus injection on plasma levels of apoptosis-related factors in aged patients with chronic heart failure].
Zhang JG; Yang N; He H; Wei GH; Gao DS; Wang XL; Wang XZ; Song GY
Chin J Integr Med; 2005 Sep; 11(3):187-90. PubMed ID: 16181532
[TBL] [Abstract][Full Text] [Related]
3. [Effects of astragalus on cardiac function and serum tumor necrosis factor-alpha level in patients with chronic heart failure].
Yang QY; Lu S; Sun HR
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):699-701. PubMed ID: 20929124
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
Hou YP; Wu JL; Fan Q; Liu MB; Yin BL; Zhang L
Clin Sci (Lond); 2007 Mar; 112(5):299-304. PubMed ID: 17020540
[TBL] [Abstract][Full Text] [Related]
5. [Effect of astragalus injection on immune function in patients with congestive heart failure].
Liu ZG; Xiong ZM; Yu XY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 May; 23(5):351-3. PubMed ID: 12800417
[TBL] [Abstract][Full Text] [Related]
6. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure.
Adamopoulos S; Parissis J; Karatzas D; Kroupis C; Georgiadis M; Karavolias G; Paraskevaidis J; Koniavitou K; Coats AJ; Kremastinos DT
J Am Coll Cardiol; 2002 Feb; 39(4):653-63. PubMed ID: 11849865
[TBL] [Abstract][Full Text] [Related]
7. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.
Nishigaki K; Minatoguchi S; Seishima M; Asano K; Noda T; Yasuda N; Sano H; Kumada H; Takemura M; Noma A; Tanaka T; Watanabe S; Fujiwara H
J Am Coll Cardiol; 1997 May; 29(6):1214-20. PubMed ID: 9137215
[TBL] [Abstract][Full Text] [Related]
8. [Study on effect of Astragalus injection in treating congestive heart failure].
Zhou ZL; Yu P; Lin D
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Oct; 21(10):747-9. PubMed ID: 12575607
[TBL] [Abstract][Full Text] [Related]
9. [Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome].
Fu Y; Xiao QM; Wang T; Chen XH; Ai YH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):691-4. PubMed ID: 17092425
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokine activation is linked to apoptotic mediator, soluble Fas level in patients with chronic heart failure.
Kinugawa T; Kato M; Yamamoto K; Hisatome I; Nohara R
Int Heart J; 2012; 53(3):182-6. PubMed ID: 22790687
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokines, soluble Fas receptor, nitric oxide and angiotensin converting enzyme in congestive heart failure.
El Sherif WT; El Tooney LF; Meki AR; Abdel Moneim A
Egypt J Immunol; 2005; 12(1):39-48. PubMed ID: 16734138
[TBL] [Abstract][Full Text] [Related]
12. [Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure].
Teplyakov AT; Berezikova EN; Shilov SN; Grakova EV; Torim YY; Efremov AV; Popova AA; Pustovetova MG; Sabirova AY; Kopyeva KV
Ter Arkh; 2016; 88(9):10-16. PubMed ID: 27735908
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy.
Parissis JT; Adamopoulos S; Karatzas D; Paraskevaidis J; Livanis E; Kremastinos D
Eur J Cardiovasc Prev Rehabil; 2005 Apr; 12(2):164-8. PubMed ID: 15785303
[TBL] [Abstract][Full Text] [Related]
14. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure.
Kourea K; Parissis JT; Farmakis D; Panou F; Paraskevaidis I; Venetsanou K; Filippatos G; Kremastinos DT
Atherosclerosis; 2008 Jul; 199(1):215-21. PubMed ID: 17991471
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
[TBL] [Abstract][Full Text] [Related]
16. [Effect of shengmai injection on TRAIL death receptor of patients with congestive heart failure].
Hong Y; Xie W; Chen CS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Dec; 25(12):1092-5. PubMed ID: 16398429
[TBL] [Abstract][Full Text] [Related]
17. Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system.
Setsuta K; Seino Y; Ogawa T; Ohtsuka T; Seimiya K; Takano T
Circ J; 2004 Aug; 68(8):747-50. PubMed ID: 15277733
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Shenqi Fuzheng injection (SFI) on immune function in patients with congestive heart failure].
Liu H; Wu X; Zhang Y; Lian W
Zhong Yao Cai; 2005 Sep; 28(9):854-6. PubMed ID: 16447880
[TBL] [Abstract][Full Text] [Related]
19. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels.
Romano E; Terenzi R; Manetti M; Peruzzi F; Fiori G; Nacci F; Bellando-Randone S; Matucci-Cerinic M; Guiducci S
J Rheumatol; 2014 Oct; 41(10):1961-5. PubMed ID: 25179850
[TBL] [Abstract][Full Text] [Related]
20. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
Nakae H; Narita K; Endo S
J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
